UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045148
Receipt number R000051516
Scientific Title Study on the safety of thiopurine preparations during pregnancy
Date of disclosure of the study information 2021/10/03
Last modified on 2022/08/13 12:45:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the safety of thiopurine preparations during pregnancy

Acronym

preMENDEL2

Scientific Title

Study on the safety of thiopurine preparations during pregnancy

Scientific Title:Acronym

preMENDEL2

Region

Japan


Condition

Condition

All diseases for which thiopurine preparations are used

Classification by specialty

Medicine in general Gastroenterology Hepato-biliary-pancreatic medicine
Pneumology Nephrology Neurology
Clinical immunology Surgery in general Obstetrics and Gynecology
Pediatrics Adult Child

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

The purpose of this study is to clarify whether there is any association between pregnancy and childbirth complications, including miscarriage and stillbirth, and child development and birth complications in patients taking thiopurine preparations, especially whether the NUDT15 gene polymorphism of the patient, male partner, and fetus is associated with these complications.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Frequency of NUDT15 genotype in infants for each NUDT15 genotype pair of parents

Key secondary outcomes

Frequency of pregnancy complications, frequency of genetic mutations in children, and analysis of transmission disequilibrium in pregnancies taking thiopurine


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients: Women over 20 years old. Any underlying disease is acceptable. Then, patients who satisfy any one of A or B.
A) Female patients who became pregnant while taking a thiopurine preparation (thiopurine can be discontinued after pregnancy)
B) Patients who have been treated with a thiopurine preparation for more than 60 days during pregnancy

Male partner (participation required*): Male patients aged 20 years or older.
Male partner with pregnancy corresponding to either A or B above

Child (participation required* for children who are pregnant while taking thiopurine): Any age or sex
All children of patient/partner pairs participating in this study
Children who became pregnant or gave birth during the period when they were not taking thiopurine products can also participate voluntarily.
However, if the child is born in a pregnancy during which the patient was taking thiopurine, the child's participation is *required* in principle.

Key exclusion criteria

Cases in which the medication status at the time of pregnancy cannot be determined.
Cases in which all the specimens of the partner (required) and the child (required for children born in pregnancies while taking thiopurine, optional for other pregnancies) are not available.

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Yoichi
Middle name
Last name Kakuta

Organization

Tohoku University Hospital

Division name

Division of Gastroenterology

Zip code

9808574

Address

1-1 Seiryo Aoba, Sendai

TEL

0227177171

Email

ykakuta@med.tohoku.ac.jp


Public contact

Name of contact person

1st name Yoichi
Middle name
Last name Kakuta

Organization

Tohoku University Hospital

Division name

Division of Gastroenterology

Zip code

980-8574

Address

1-1 Seiryo Aoba, Sendai

TEL

0227177171

Homepage URL

https://premendel.ibd.ai/

Email

ykakuta@med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tohoku University Graduate School of Medicine Ethics Committee

Address

1-1 Seiryo-machi, Aoba-ku, Sendai

Tel

022-717-3867

Email

med-kenkyo@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 09 Month 28 Day

Date of IRB

2021 Year 09 Month 29 Day

Anticipated trial start date

2021 Year 10 Month 04 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2025 Year 03 Month 31 Day


Other

Other related information

None


Management information

Registered date

2021 Year 08 Month 13 Day

Last modified on

2022 Year 08 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051516